Template:Meglumine antimoniate: Difference between revisions

Latest revision as of 03:45, 7 January 2014

Meglumine Antimoniate
GLUCANTIM^® WHO Prescribing Information
Description
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Dosage and Administration
How Supplied

@@ Line 5: / Line 5: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meglumine antimoniate description|Description]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meglumine antimoniate clinical pharmacology|Clinical Pharmacology]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meglumine antimoniate microbiology|Microbiology]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meglumine antimoniate indications and usage|Indications and Usage]]
@@ Line 17: / Line 13: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meglumine antimoniate adverse reactions|Adverse Reactions]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meglumine antimoniate drug interactions|Drug Interactions]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meglumine antimoniate overdosage|Overdosage]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meglumine antimoniate dosage and administration|Dosage and Administration]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meglumine antimoniate how supplied|How Supplied]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meglumine antimoniate labels and packages|Labels and Packages]]
 |-
 |}